Entrada Therapeutics

layoffs
Biotech

Entrada lays off 20% of staff weeks after having FDA hold lifted

Pink slips have followed the green light at Entrada, with the biotech setting out plans to reduce its workforce weeks after the FDA lifted a hold.
Nick Paul Taylor Apr 30, 2025 4:38am
Go sign green light

Entrada's 2-year ordeal ends as FDA lifts hold on DMD drug

Feb 24, 2025 11:08am
visual of a parachute

Acadia brings BMS vet on board as CEO—Chutes & Ladders

Sep 27, 2024 8:30am
FDA stop sign

FDA rebuffs Entrada's attempt to get DMD clinical hold lifted

Nov 22, 2023 9:25am
image of a few paragliders

Amarin CEO abruptly resigns—Chutes & Ladders

Apr 7, 2023 9:30am
FDA

Fresh from Vertex payday, Entrada's DMD plans derailed by FDA

Dec 20, 2022 8:45am